Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients

por da Cunha-Bang, C, Simonsen, J, Rostgaard, K, Geisler, C, Hjalgrim, H, Niemann, C U
Publicado 2016

P1596: PREDIAGNOSTIC ANTIMICROBIAL USE IN CLL, MM, FL AND DLBCL

por Packness, E. M., Andersen, M. A., Rostgaard, K., Hjalgrim, H., Niemann, C. U., Brieghel, C.
Publicado 2022

P1264: HEMATOPOIETIC CLONES WITH TP53 MUTATIONS EXPAND IN PATIENTS WITH MCL DURING LENALIDOMIDE-BASED THERAPY

por Husby, S., Bæch-Laursen, C., Favero, F., Jespersen, J. S., Eskelund, C. W., Hutchings, M., Pedersen, L. B., Niemann, C. U., Weischenfeldt, J., Geisler, C., Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M., Grønbæk, K.
Publicado 2022

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation

por Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, C. U., Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P., Pospisilova, S.
Publicado 2018